好评率
100%
  • Cao Y; Yao W; Yang T, et al., Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and in vivo validation. Phytomedicine 2024, 132, 155820.
    IF: 6.7
    Year: 2024 Journal: Phytomedicine
    PubMed: 39004032
  • Li N; Du Z; Li Y, et al., p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation. Stem Cells Int 2021, 2021, 4968649.
    IF: 5.443
    Year: 2021 Journal: Stem Cells Int
    PubMed: 34976070
  • Qi A; Ru W; Yang H, et al., Circular RNA ACTA1 Acts as a Sponge for miR-199a-5p and miR-433 to Regulate Bovine Myoblast Development through the MAP3K11/MAP2K7/JNK Pathway. J Agric Food Chem 2022.
    IF: 5.279
    Year: 2022 Journal: J Agric Food Chem
    PubMed: 35234473
  • Zhu N; Meng S; Mao L, et al., Amino polycarboxylic acids-modified abiraterone derivatives as potential injectable anti-prostate cancer agents. Bioorg Chem 2024, 153, 107824.
    IF: 4.5
    Year: 2024 Journal: Bioorg Chem
    PubMed: 39305608
  • Lu T; Zheng Y; Chen X, et al., miR-743b-3p promotes hepatic lipogenesis via branched-chain amino acids (BCAA) metabolism by targeting PPM1K in aged mice. Arch Gerontol Geriatr 2024, 123, 105424.
    IF: 4
    Year: 2024 Journal: Arch Gerontol Geriat
    PubMed: 38565071
  • Sun B; Zhao Z; Meng Q, et al., CDK1‑induced regulation of p53 phosphorylation at Ser315 mediates cell cycle arrest and apoptosis of macrophages infected with clinical isolates of Mycobacterium tuberculosis. Mol Med Rep 2026, 33 (1).
    IF: 3.5
    Year: 2025 Journal: Mol Med Rep
    PubMed: 41268607
  • Guo J; Tang Q; Wang Q, et al., Pifithrin-alpha enhancing anticancer effect of topotecan on p53-expressing cancer cells. Eur J Pharm Sci 2019, 128, 61-72.
    IF: 3.466
    Year: 2018 Journal: Eur J Pharm Sci
    PubMed: 30472223
  • Fan Y; Ma K; Jing J, et al., Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells. J Cancer 2020, 11 (1), 25-40.
    IF: 3.182
    Year: 2020 Journal: J Cancer
    PubMed: 31892970
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序